Avidity Biosciences, Inc.

RNA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$219,868$185,082$340,396$320,448
Short-Term Investments$1,281,629$410,269$270,331$85,095
Receivables$28,222$8,623$3,875$900
Inventory$0$0$0$0
Other Curr. Assets$12,571$7,333$8,340$4,698
Total Curr. Assets$1,542,290$611,307$622,942$411,141
Property Plant & Equip (Net)$18,289$16,652$15,009$15,589
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,316$596$849$850
Total NC Assets$21,605$17,248$15,858$16,439
Other Assets$0$0$0$0
Total Assets$1,563,895$628,555$638,800$427,580
Liabilities
Payables$8,461$8,809$4,637$2,806
Short-Term Debt$3,844$3,639$3,105$1,769
Tax Payable$0$0$0$0
Deferred Revenue$20,987$28,365$5,041$0
Other Curr. Liab.$64,726$39,867$39,125$25,083
Total Curr. Liab.$98,018$80,680$51,908$29,658
LT Debt$2,957$6,213$7,582$9,960
Deferred Rev, NC$37,961$40,898$1,235$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$6,532
Total NC Liab.$40,918$47,111$8,817$16,492
Other Liabilities$0$0$0$0
Cap. Leases$6,801$9,852$10,687$11,729
Total Liabilities$138,936$127,791$60,725$46,150
Equity
Pref Stock$0$0$0$0
Common Stock$12$8$7$5
Retained Earnings-$893,066-$570,764-$358,544-$184,549
AOCI$2,902$125-$2,698-$187
Other Equity$2,315,111$1,071,395$939,310$566,161
Total Equity$1,424,959$500,764$578,075$381,430
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,563,895$628,555$638,800$427,580
Net Debt-$213,067-$175,230-$329,709-$308,719